Start » Publications

Hsp60 and Hspl0 as antitumor molecular agents.

Francesco Cappello, Anna M Czarnecka, Giampiero La Rocca, Antonino Di Stefano, Giovanni Zummo, Alberto J L Macario

Department of Experimental Medicine, University of Palermo, Palermo, Italy.

Journal Article: Cancer biology & therapy (impact factor: 2.71). 05/2007; 6(4):487-9.

Abstract

The molecular chaperones Hsp60 and Hsp10 are, according to recent reports, involved in cancer development and progression. We, for instance, have found that their expression varies with distinctive patterns in different malignancies: they are overexpressed in colorectal, exocervical and prostate carcinogenesis, and colorectal cancer progression, but they are downregulated during bronchial carcinogenesis. There is also evidence showing that Hsp60 and Hsp10 can be used as therapeutic agents, for example in rheumatoid arthritis. In view of these findings we want now to call attention to the potential of Hsp60 and Hsp10 in cancer therapy.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Science & Research Jobs

View jobs

Keywords

cancer therapy
 
different malignancies
 
expression varies
 
prostate carcinogenesis
 
rheumatoid arthritis
 
therapeutic agents